Pegasys® (peginterferon alfa-2a)

is a once-a-week self injectable medication approved by the U.S. Food and Drug Administration to treat adults who have a chronic infection with hepatitis C virus (HCV) or hepatitis B virus (HBV) who show clinical signs of liver damage with no prior treatment with interferon. Read more about Pegasys